Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 033711/0927 | |
| Pages: | 5 |
| | Recorded: | 09/10/2014 | | |
| Attorney Dkt #: | 02020.102US1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/08/2016
|
Application #:
|
14382178
|
Filing Dt:
|
08/29/2014
|
|
Publication #:
|
|
Pub Dt:
|
01/29/2015
| | | | |
|
Title:
|
CRYSTALLINE FORMS OF 1-(3-TERT-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(5-FLUORO-2-(1-(2-HYDROXYETHYL)-INDAZOL-5-YLOXY)BENZYL)UREA HYDROCHLORIDE
|
|
|
Assignee
|
|
|
|
|
| 3200 WALNUT STREET |
| BOULDER, COLORADO 80301 |
|
|
Correspondence name and address
|
| |
ARRAY BIOPHARMA, INC.
|
| |
3200 WALNUT STREET
|
| |
BOULDER, CO 80301
|
Search Results as of:
05/28/2024 07:39 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
